FOI 5069 – Documents concerning Vyvanse
FOI number:
5069-2024
FOI release date:
Publication type:
Report
Audience:
General public
Description:
This request includes 2 documents:
- Document: Therapeutic Goods Act 1989 Approval under subsection 19A(1) – Notice of approval for the importation and supply of specified therapeutic goods
- Letter by Medsurge Healthcare on the Shortage of VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle (AUST R: 199226), VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle (AUST R: 284021) and alternate supply arrangement under Section 19A of the Therapeutic Goods Act 1989